Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
12001
Cross sectional study of mode of delivery and maternal and perinatal outcomes in mainland China
Published 2017“…Intrapartum indicated CD was associated with an increased risk of PPH (aOR = 1.68, CI = 1.50–1.89) compared to SVD. Compared to SVD, antepartum non-indicated CD was associated with lower likelihood of neonatal death (aOR = 0.14, CI = 0.06–0.34), neonatal ICU admission (aOR = 0.50, CI = 0.36–0.69), 5-minute Apgar<4 (aOR = 0.06, CI = 0.10–0.36), and respiratory distress syndrome (RDS) (aOR = 0.31, CI = 0.16–0.58), but not significantly associated with changes in rates of infection, hypoxic ischemic encephalopathy (HIEE), birth trauma or meconium aspiration rates.…”
-
12002
-
12003
Plasmid constructs used in this study.
Published 2025“…The <i>PRAME-AS</i> knockout cells showed a decrease in migration, proliferation, stemness, and viability. …”
-
12004
Oligonucleotides used in this study.
Published 2025“…The <i>PRAME-AS</i> knockout cells showed a decrease in migration, proliferation, stemness, and viability. …”
-
12005
Zpg does not function as a hemichannel.
Published 2022“…<p>(A-D) <i>zpg</i> mutants rescued with genomic rescue constructs in which one or more cysteine residues were mutated, hindering the formation of gap junctions, have rudimentary testes and no Zpg is detected by antibody staining (green in A-D; single channels depicted in grey in A’-D’; wt in A-A’; <i>zpg</i> C6S, B-B’:, <i>zpg</i> C145S, C-C’; <i>zpg</i> C236S, D-D’). …”
-
12006
Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance
Published 2024“…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…”
-
12007
Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance
Published 2024“…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…”
-
12008
Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population
Published 2018“…</p> <p><b>Methods:</b> A retrospective observational longitudinal study of subjects with obesity was conducted using the General Electric Centricity electronic medical record database. …”
-
12009
IG feature selection process.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12010
RFE feature selection process.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12011
CICID2017 dataset information.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12012
Shows the basic architecture of an autoencoder.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12013
Architecture of deep neural networks.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12014
Proposed model framework.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12015
WUSTL-EHMS-2020 dataset information.
Published 2025“…The proposed model employs Information Gain (IG) and Recursive Feature Elimination (RFE) in parallel to select the top 50% of features, from which intersection and union subsets are created, followed by a deep autoencoder (DAE) to reduce dimensionality without losing important data. …”
-
12016
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…XZB108, selectively inhibited HDAC8 (IC<sub>50</sub> = 0.90 ± 0.014 μM), suggesting that it may be a promising nonhydroxamate HDAC8 inhibitor. …”
-
12017
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…XZB108, selectively inhibited HDAC8 (IC<sub>50</sub> = 0.90 ± 0.014 μM), suggesting that it may be a promising nonhydroxamate HDAC8 inhibitor. …”
-
12018
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…XZB108, selectively inhibited HDAC8 (IC<sub>50</sub> = 0.90 ± 0.014 μM), suggesting that it may be a promising nonhydroxamate HDAC8 inhibitor. …”
-
12019
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…XZB108, selectively inhibited HDAC8 (IC<sub>50</sub> = 0.90 ± 0.014 μM), suggesting that it may be a promising nonhydroxamate HDAC8 inhibitor. …”
-
12020
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer
Published 2024“…XZB108, selectively inhibited HDAC8 (IC<sub>50</sub> = 0.90 ± 0.014 μM), suggesting that it may be a promising nonhydroxamate HDAC8 inhibitor. …”